C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production and glomerulonephropathy in mice-Reference-Cited by-同舟云学术

C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production and glomerulonephropathy in mice

Published:2016-03-16 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Atanasio Amanda,Decman Vilma,White Derek,Ramos Meg,Ikiz Burcin,Lee Hoi-Ching,Siao Chia-Jen,Brydges Susannah,LaRosa Elizabeth,Bai Yu,Fury Wen,Burfeind Patricia,Zamfirova Ralica,Warshaw Gregg,Orengo Jamie,Oyejide Adelekan,Fralish Michael,Auerbach Wojtek,Poueymirou William,Freudenberg Jan,Gong Guochun,Zambrowicz Brian,Valenzuela David,Yancopoulos George,Murphy Andrew,Thurston Gavin,Lai Ka-Man Venus

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep23204.pdf

Reference65 articles.

1. DeJesus-Hernandez, M. et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72, 245–256 (2011).

2. Renton, A. E. et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72, 257–268 (2011).

3. van Swieten, J. C. & Grossman, M. FTD/ALS families are no longer orphaned: the C9ORF72 story. Neurology 79, 962–964 (2012).

4. Donnelly, C. J., Grima, J. C. & Sattler, R. Aberrant RNA homeostasis in amyotrophic lateral sclerosis: potential for new therapeutic targets? Neurodegener. Dis. Manag. 4, 417–437 (2014).

5. Haeusler, A. R. et al. C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature 507, 195–200 (2014).

Cited by 219 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. C9orf72repeat expansion-carrying iPSC-microglia from FTD patients show increased phagocytic activity concomitantly with decreased number of autophagosomal-lysosomal vesicles;2024-08-17

2. Promising animal models for amyotrophic lateral sclerosis drug discovery: a comprehensive update;Expert Opinion on Drug Discovery;2024-08-08

3. The Current Potential Pathogenesis of Amyotrophic Lateral Sclerosis;Molecular Neurobiology;2024-06-03

4. Updates on Disease Mechanisms and Therapeutics for Amyotrophic Lateral Sclerosis;Cells;2024-05-21

5. C9ORF72 hexanucleotide repeat expansion: From ALS and FTD to a broader pathogenic role?;Revue Neurologique;2024-05